Translating AI-Driven Neoantigen Discovery Into Clinical Reality: Lessons From Evaxion’s Latest Trial Readouts
Time: 12:00 pm
day: Conference Day Two
Details:
• Evaluating how AI-based prediction influences trial design, patient selection, and antigen prioritization strategies
• Addressing logistical and operational learnings from moving an AI-predicted vaccine into the clinic
• Outlining next steps to scale trials and build confidence in AI-enabled cancer vaccine platforms
